143 related articles for article (PubMed ID: 18316591)
41. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
[TBL] [Abstract][Full Text] [Related]
42. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
43. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G
Blood; 2003 Mar; 101(5):1919-27. PubMed ID: 12424201
[TBL] [Abstract][Full Text] [Related]
44. Dlx5- and Dlx6-mediated chondrogenesis: Differential domain requirements for a conserved function.
Hsu SH; Noamani B; Abernethy DE; Zhu H; Levi G; Bendall AJ
Mech Dev; 2006 Nov; 123(11):819-30. PubMed ID: 17027239
[TBL] [Abstract][Full Text] [Related]
45. Herpesvirus saimiri Tip gene causes T-cell lymphomas in transgenic mice.
Wehner LE; Schröder N; Kamino K; Friedrich U; Biesinger B; Rüther U
DNA Cell Biol; 2001 Feb; 20(2):81-8. PubMed ID: 11244565
[TBL] [Abstract][Full Text] [Related]
46. Split Hand-Foot and Deafness in a Patient with 7q21.13-q21.3 Deletion Not Including the
Ambrosetti I; Bernardini L; Pollazzon M; Giuffrida MG; Guida V; Peluso F; Baroni MC; Polizzi V; Napoli M; Rosato S; Trimarchi G; Gelmini C; Caraffi SG; Wischmeijer A; Frattini D; Novelli A; Garavelli L
Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628577
[TBL] [Abstract][Full Text] [Related]
47. Dlx5/6-enhancer directed expression of Cre recombinase in the pharyngeal arches and brain.
Ruest LB; Hammer RE; Yanagisawa M; Clouthier DE
Genesis; 2003 Dec; 37(4):188-94. PubMed ID: 14666512
[TBL] [Abstract][Full Text] [Related]
48. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
49. Isolation and identification of homeobox genes from the human placenta including a novel member of the Distal-less family, DLX4.
Quinn LM; Johnson BV; Nicholl J; Sutherland GR; Kalionis B
Gene; 1997 Mar; 187(1):55-61. PubMed ID: 9073066
[TBL] [Abstract][Full Text] [Related]
50. Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency.
Bouhali K; Dipietromaria A; Fontaine A; Caburet S; Barbieri O; Bellessort B; Fellous M; Veitia RA; Levi G
Hum Mol Genet; 2011 Jul; 20(13):2642-50. PubMed ID: 21505076
[TBL] [Abstract][Full Text] [Related]
51. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia.
Wright DD; Sefton BM; Kamps MP
Mol Cell Biol; 1994 Apr; 14(4):2429-37. PubMed ID: 8139546
[TBL] [Abstract][Full Text] [Related]
53. Functional characterization of tissue-specific enhancers in the DLX5/6 locus.
Birnbaum RY; Everman DB; Murphy KK; Gurrieri F; Schwartz CE; Ahituv N
Hum Mol Genet; 2012 Nov; 21(22):4930-8. PubMed ID: 22914741
[TBL] [Abstract][Full Text] [Related]
54. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
55. Expression of homeobox genes in the mouse olfactory epithelium.
Parrilla M; Chang I; Degl'Innocenti A; Omura M
J Comp Neurol; 2016 Oct; 524(14):2713-39. PubMed ID: 27243442
[TBL] [Abstract][Full Text] [Related]
56. HOXC4, HOXC5, and HOXC6 expression in non-Hodgkin's lymphoma: preferential expression of the HOXC5 gene in primary cutaneous anaplastic T-cell and oro-gastrointestinal tract mucosa-associated B-cell lymphomas.
Bijl JJ; van Oostveen JW; Walboomers JM; Horstman A; van den Brule AJ; Willemze R; Meijer CJ
Blood; 1997 Nov; 90(10):4116-25. PubMed ID: 9354682
[TBL] [Abstract][Full Text] [Related]
57. Dlx5, the mouse homologue of the human-imprinted DLX5 gene, is biallelically expressed in the mouse brain.
Kimura MI; Kazuki Y; Kashiwagi A; Kai Y; Abe S; Barbieri O; Levi G; Oshimura M
J Hum Genet; 2004; 49(5):273-7. PubMed ID: 15362572
[TBL] [Abstract][Full Text] [Related]
58. Dlx5 and Dlx6 can antagonize cell division at the G
MacKenzie RK; Sankar PR; Bendall AJ
BMC Mol Cell Biol; 2019 Apr; 20(1):8. PubMed ID: 31041891
[TBL] [Abstract][Full Text] [Related]
59. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
60. Regulatory roles of conserved intergenic domains in vertebrate Dlx bigene clusters.
Ghanem N; Jarinova O; Amores A; Long Q; Hatch G; Park BK; Rubenstein JL; Ekker M
Genome Res; 2003 Apr; 13(4):533-43. PubMed ID: 12670995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
